Isracann Biosciences (Isracann Biosciences) Revenue : $0.00 Mil (TTM As of Aug. 2022)

Isracann Biosciences Revenue Chart

Isracann Biosciences Annual Data
	Trend	May13	May14	May15	May16	May17	May18	May19	May20	May21	May22
Revenue		Get a 7-Day Free Trial					0.91	-	-	-	-

Isracann Biosciences Quarterly Data
	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22
Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Isracann Biosciences's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Isracann Biosciences's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Isracann Biosciences's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Isracann Biosciences's Revenue distribution charts can be found below:

* The bar in red indicates where Isracann Biosciences's Revenue falls into.

Isracann Biosciences Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Aug. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isracann Biosciences  (OTCPK:ISCNF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Isracann Biosciences Revenue Related Terms

Thank you for viewing the detailed overview of Isracann Biosciences's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Isracann Biosciences (Isracann Biosciences) Business Description